Cannabis use may impair the ability of people with multiple sclerosis to accurately self-assess their cognitive performance.

Social disruption from the COVID-19 pandemic is linked to increased odds of substance use in adolescents with chronic pain.

Virtual primary care sick visits for very young children are more likely to result in emergency department visits in the following 3 days.

Menopause hormone therapy use does not appear to be associated with an increased risk for dementia for postmenopausal women.

Short-term treatments of cannabinoid products with comparable and high THC-to-CBD ratios may offer minor improvements in pain.

Evidence from observational studies shows that endometriosis and migraine frequently co-occur, with each condition linked to ...

Clinical outcomes from routine practice confirm ocrelizumab effectiveness in relapsing MS, with low rates of disability worsening over 4 years.

Older age may be associated with poorer functional outcomes after spinal cord injury, but does not seem to affect neurologic ...

Private equity firms have been identifying areas with a higher prevalence of autism and investing in ASD services in those areas.

The FDA has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1).

The strongest factor associated with no MMR vaccination by the age of 2 appears to be late administration of the 2- and 4-month MMR vaccine.

Researchers assessed the risk for serious infection during pregnancy and postpartum based on TNF inhibitor exposure among women with chronic inflammatory disease.